The First EJ Ocular Oncology Case at Tulane University was a Success!
|
|
February 26, 2026: The first EJ Ocular Oncology case has been a success! Congrats to Dr. Finger, Dr. Tomar, and Dr. Harris pictured above!
Tulane University launched Louisiana’s only comprehensive ophthalmic plaque brachytherapy program for the treatment of eye cancers.
Establishing this program required extensive coordination across multiple medical and safety teams to ensure patient safety and regulatory compliance. This milestone represents a major advancement for cancer care in Louisiana. Patients who previously had to leave the state for this treatment can now receive cutting-edge eye cancer therapy close to home, reducing travel burden while maintaining the highest standards of care.
Tulane University launched Louisiana’s only comprehensive ophthalmic plaque brachytherapy program for the treatment of eye cancers.
Establishing this program required extensive coordination across multiple medical and safety teams to ensure patient safety and regulatory compliance. This milestone represents a major advancement for cancer care in Louisiana. Patients who previously had to leave the state for this treatment can now receive cutting-edge eye cancer therapy close to home, reducing travel burden while maintaining the highest standards of care.
|
|
Tulane's Ophthalmology Department is dedicated to excellence in training and clinical care and to advancing research to discover and develop new, more effective treatments. The department has a long, illustrious history of attracting strong faculty dedicated to teaching and of providing pro bono services to those in great need of our care.
Read more about them here: https://medicine.tulane.edu/ophthalmology
